Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price
(Reuters) -Bristol Myers Squibb said on Monday that it plans to launch its schizophrenia treatment C...
22nd September, 2025
(Reuters) -Bristol Myers Squibb said on Monday that it plans to launch its schizophrenia treatment C...
22nd September, 2025
SAN SEBASTIAN (Reuters) -Bayer Chief Executive Bill Anderson said the company is making "remarkable...
22nd September, 2025
(Reuters) -Shares in Roche Holding rose around 2% on Monday, outperforming a broadly unchanged Europ...
22nd September, 2025
HONG KONG (Reuters) -Chinese-controlled container line Sea Legend will launch the first direct China...
22nd September, 2025
(Reuters) -Pan-European stock market operator Euronext announced on Monday the launch of a new serie...
22nd September, 2025
By Alessandro Parodi (Reuters) -At least a third of surveyed companies have paused or delayed stainl...
22nd September, 2025
By Alessandro Parodi and Javi West Larrañaga BARCELONA (Reuters) -When Javier Hernandez went car sho...
22nd September, 2025
By Ben Blanchard TAIPEI (Reuters) -In an arms market long dominated by the United States, Europe rai...
22nd September, 2025
TOKYO (Reuters) -Nissan Motor said on Monday it has started testing a new driver-assistance system t...
22nd September, 2025
By Haripriya Suresh and Sai Ishwarbharath B BENGALURU (Reuters) -India's $283 billion information te...
21st September, 2025
(Reuters) -Electric vehicle maker Polestar is recalling 27,816 cars in the United States due to a re...
20th September, 2025
By Manuel Ausloos MARSEILLE, France (Reuters) - A French couple is training in the Mediterranean to...
20th September, 2025